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Introduction 
 
Enzymes from the lyase (EC 4.1), ligase (EC 6.4) and hydrolase 
(EC 3.1, 3.7) classes have been explored for organic synthesis of 
value-added compounds and pharmaceuticals due to their ability to 
catalyze carbon-carbon bond formation (for reviews please see [1-4]). 
Natural enzymes however, do not exist for many industrially 
important transformations and therefore there is practical interest in 
tailoring the enzymes for novel functionalities. This can be 
accomplished through directed evolution approaches, involving 
random mutagenesis followed by screening of resultant enzyme 
variants for desired properties [5-8]. However, this approach tends to 
be labour intensive and the requirements for a screening method can 
limit the type of reactions that can be efficiently selected. Rational 
design approaches, involving site-specific mutagenesis of key residues 
of the enzyme is an alternative means to alter enzymes’ properties or 
function. This often requires an intimate knowledge of the enzyme’s 
structure and its relationship to function. In some cases, when 
functional significance of an amino acid is unknown, “semi-rational” 
approaches can be employed, targeting a specific amino acid for 
multiple mutations.  There have been a number of recent examples of 
successful rational or semi-rational design of C-C bond forming 
enzymes, which will be the focus of this review. Some exciting 
developments on the de novo rational design of enzymes to catalyze 
novel C-C bond forming chemistries are also presented. 
 
Alterations to Substrate Specificity 
 
One of the main limitations of enzymes as catalysts for synthetic 
chemistry is that natural enzymes can only transform a limited range 
of substrates. In the cases discussed below, modifications of enzymes’ 
substrate binding sites could have profound effects on substrate 
specificity. 
While many enzymes have evolved to accept phosphorylated 
substrates,  synthetic chemists rarely want to prepare phosphorylated  
 
 
 
 
 
 
 
 
products. 2-deoxyribose-5-phosphate aldolase (DERA) has been 
modified to increase its preference for non-phosphorylated substrates. 
DERA is unique among aldolases as it catalyzes the reversible 
asymmetric aldol addition reaction of two aldehydes, acetaldehyde 
and D-glyceraldehyde-3-phosphate, to generate D-2-deoxyribose-5-
phosphate [9]. Using the 1.05 Å crystal structure of DERA in 
complex with its natural substrate, two positively charged residues 
(K172 and R207) and three neutral active site residues (G205, S238, 
S239), located in the phosphate binding pocket were replaced with 
negatively charged aspartate or glutamate to change the enzyme 
specificity from the utilization of a negatively charged phosphorylated 
substrate to a non-phosphorylated neutral D-2-deoxyribose (DR) 
substrate. In each of the mutants, specificity constants (kcat/Km) for 
the natural substrate were reduced by 11-fold to 108-fold.  Specificity 
constants for DR were only improved in the S238D variant by 2.5-
fold, possibly due to favorable hydrogen bonding interactions between 
the aspartate side chain carboxylate at position 238 and the terminal 
hydroxyl of D-glyceraldehyde. Interestingly, the S238D variant was 
able to catalyze a novel sequential aldol reaction using 3-
azidopropinaldehyde, which is not a substrate for the wild-type 
enzyme, as the first acceptor and two molecules of acetaldehyde as 
donor to form an azidoethyl pyranos. This is a key intermediate in the 
synthesis of Lipitor™, a statin drug used for lowering blood 
cholesterol. 
Specificity of an enzyme can also be altered by steric 
modifications to the active site of an enzyme. The substrate specificity 
of BphI, a class II pyruvate aldolase [10], was altered using the crystal 
structure of an orthologous aldolase, DmpG (PDB 1NVM), as a 
guide [11]. The natural substrate 4-hydroxy-2-oxopentanoate and 4-
hydroxy-2-oxoacids containing unfunctionalized aldehydes of 
different lengths were modeled into the active site of DmpG [12] 
(Figure 1). Leu-87, which was proposed to be located proximal to the 
C4-methyl of 4-hydroxy-2-oxopentanoate and Leu-89, located at the 
opposite side of the active site from the pyruvvl moiety in BphI were 
replaced with smaller alanine residues. The replacement of Leu-87 
with alanine reduced the specificity constants of the enzyme toward 
acetaldehyde by 32-fold while maintaining the same specificity 
constant for propionaldehyde as in the wild-type enzyme. The L89A 
variant exhibited similar kcat/Km values for acetaldehyde and 
propionaldehyde as in the wild-type enzyme, however specificities   
toward butyraldehyde, pentaldehyde, and hexaldehyde increased
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dramatically. For example, the specificity of the L89A variant for 
pentaldehyde was ~50-fold higher than that of the wild type, making 
it a more efficient enzyme (kcat/Km = 23.3 ± 2.8 M-1 s-1) for 
utilization of this longer chain aldehyde than the wild-type enzyme 
for its natural substrate, acetaldehyde (kcat/Km = 13.4 ± 0.8 M-1 s-1). 
These results demonstrate that the alkyl moiety of the aldehyde 
substrate extends towards Leu-89, and reducing the side chain size of 
this residue can create an enzyme with increased specificity for longer 
chain aldehydes.  
Dihydroxyacetone (DHA) and dihydroxyacetone phosphate 
(DHAP)-dependent aldolases have been extensively utilized in organic 
synthesis because they catalyze stereoselective aldol additions leading 
to the formation of useful chiral polyhydroxylated structures [13]. A 
number of studies have successfully utilized rational and semi-rational 
approaches, guided by X-ray crystal structures, to alter the substrate 
specificity through mutations in the phosphate-binding and other 
active site residues [14, 15]. 
Of special attention is FucA, a L-fuculose-1-phosphate aldolase 
from E. coli. DHAP aldolases, such as FucA, are specific for the 
DHAP donor substrate but can accept structurally diverse aldehyde 
acceptors. In spite of this diverse specificity towards the aldehyde 
acceptors, the enzyme does not effectively catalyze reactions involving 
N-Cbz-amino aldehydes (Cbz = benzyloxycarbonyl) containing α-
branched substituents to produce polyhdroxylated pyrrolizidines 
glycosidase inhibitors. Using the crystal structure of FucA [16], 
Clapés and colleagues targeted Phe-131 and Phe-206 that compose a 
hydrophobic wall at the binding site for the natural acceptor 
substrate, L-lactaldehyde. Single alanine mutations of these residues 
were created to effectively remove these aromatic residues that 
sterically hinder the productive binding of branched α-substituted N-
Cbz-amino aldehydes. While F131A and F206A variants exhibited a 
5 to 100-fold reduction in specific activity for the natural reaction, 
the F131A was observed to catalyze the aldol addition reactions of 
DHAP to various N-Cbz-amino aldehyde derivatives 4 to 25-fold 
higher than that of wild-type FucA [17]. Moreover, F131A displayed 
aldol activity with (S)- and (R)-N-Cbz-prolinal, whereas no 
detectable activity was observed in wild-type FucA for the (R)-
enantiomer. Computational binding models and molecular dynamic 
simulations further indicated that the phenyl group of Cbz can 
occupy the space generated by the F131A and F206A and that in 
F131A, the Cbz-phenyl group is stabilized by a π-cation interaction 
with the charged ε-amine of Lys-205. This interaction would 
therefore increase binding affinity of these substrates relative to the 
wild-type enzyme. Thus, a single point mutation effectively eliminated 
a steric constraint, allowing for a non-natural π-cation interaction, 
allowing for the synthesis of novel polyhdroxylated pyrrolizidines of 
the hyacinthacine and alexine types. 
Another such aldolase which has received considerable attention is 
the class I D-fructose-6-phosphate aldolase, FsaA from E. coli. Its 
catalytic potential arises from the fact that the enzyme can catalyze 
the asymmetric synthesis of polyhydroxylated compounds utilizing 
unphosphorylated dihydroxyacetone (DHA) instead of the more 
expensive DHAP. The aldolase catalyzes the reversible aldol addition 
of DHA, hydroxyacetone (HA) and hydroxybutanone (HB) with a 
variety of acceptor aldehydes. To improve the enzyme’s specificity for 
DHA by allowing hydrogen bonding to occur with the C-1 hydroxyl 
of this substrate, an A129S variant was constructed. The kcat/Km 
values for this variant towards DHA increased by 17-fold [18]. It is 
thought that the serine stabilizes the DHA donor substrate and may 
also be involved in the stabilization of the Schiff-base intermediate 
[19]. Despite the ability for the enzyme to utilize a number of donor 
substrates, the enzyme has limitations in its acceptor substrate 
tolerance. In an attempt to rationally design the enzyme to complete 
the aldol addition of DHA or HA to α-substituted aminoaldehydes, 
such as (S)- and (R)- N-Cbz-alaninals, Clapés and co-workers 
identified a putative residue in the active site thought to be involved 
in acceptor substrate-binding. Substitution of Ala-165 with glycine 
was envisaged to create more space in the active site to accommodate 
the C-α substituents of the aldehyde acceptors.  Indeed, the variant 
catalyzed aldol addition reaction using HA and DHA as the donor 
and α-substituted aminoaldehydes as the acceptor with specific 
activities 4 to 175-fold higher than the wild-type enzyme [20]. 
Combining the two mutations, A129S and A165G, improved the 
activity of the enzyme in catalyzing the aldol addition of DHA and 
HA to selected aldehydes. These mutations did not result in changes 
in the stereochemical outcome of the reaction suggesting that the 
active site is not substantially altered. 
Figure 1. Active site of pyruvate aldolase and the reaction it catalyzes. (A) Active site of DmpG, an ortholog of BphI, containing the modeled substrate 4-
hydroxy-2-oxohexanoate (HOHA). The alkyl chain of the 4-hydroxy-2-oxoacid extends towards Leu-89.  Carbon atoms of the substrate are colored cyan, and the 
residues in the substrate binding sites are colored gray. Numbers correspond to residues in BphI. (B) The enzyme, BphI, catalyzes the aldol addition reaction 
between pyruvate and an aldehyde. R= CH3 and C5H11 for acetaldehyde and pentaldehyde, respectively. 
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Benzophenone derivatives constitute a class of secondary plant 
metabolites that include a number of pharmacologically active 
constituents, including garcinol and gambogic acid. The formation of 
the carbon skeleton of these benzophenone derivatives is catalyzed by 
benzophenone synthase (BPS), a type II polyketide synthase. In 
Hypericum androsaemum, BPS catalyzes the iterative condensation of 
benzoyl-CoA with three molecules of malonyl-CoA to give a linear 
tetraketide intermediate, which subsequently cyclizes into 2,4,6-
trihydroxybenzophenone by Claisen condensation [21]. The enzyme 
also synthesizes small amounts of 6-phenyl-4-hydroxy-2-pyrone 
(phenylpyrone). Using molecular modeling based on the crystal 
structure of chalcone synthase (59.1% sequence identity with 
benzophenone synthase) (PDB 1CGZ) [22] as a guide, an attempt 
was made to alter substrate specificity. In the wild-type enzyme, Thr-
135 forms hydrogen bonds with the backbone of Gly-166 (Figure 2). 
A T135L variant was created such that the leucine side chain 
protrudes into the elongation cavity and at the same time disrupting 
the hydrogen bond formed with Gly-166.  This resulted in the 
opening of a new pocket within the active site to accommodate a 
phenyl group of the substrate. Relative to the wild-type enzyme, the 
variant catalyzed the addition of only two acetyl groups from 
malonyl-CoA to the benzoyl starter unit forming phenylpyrone. The 
Figure 2. Postulated mechanism of wild-type BPS and the T135L variant. (A) The wild-type enzyme catalyzes the condensation of benzoyl-CoA with three 
malonyl-CoAs to form a tetraketide which cyclizes to 2,4,6-trihydroxybenzophenone. The T135L variant is only able to catalyze the condensation of benzoyl-
CoA with two malonyl-CoAs, forming a triketide which cyclizes to 6-phenyl-4-hydroxy-2-pyrone. (B) Differences in active site structure result in altered product 
specificity. In the wild-type enzyme the benzene ring of benzoyl-CoA projects into the elongation tunnel as acetyl units from malonyl-CoA are added. This 
tunnel is open due to hydrogen bonding between Thr-135 and the backbone amides of Gln-165 and Gly-166. In the T135L variant, leucine projects into the 
tunnel, resulting in a steric block while eliminating the hydrogen-bonding with Gln-165 and Gly-166 and resulting in the formation of a new pocket. Favorable 
hydrophobic interactions between Leu-135 and the benzene ring of benzoyl-CoA result in a new orientation of substrate binding and elongation in the T135L 
variant. 
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catalytic efficiency (kcat/Km) for the variant was almost unchanged 
relative to the wild-type enzyme as a 8-fold reduction in kcat was offset 
by a 8-fold reduction in Km. When 3-hydroxybenzoyl-CoA is used as 
the starter substrate, the wild-type enzyme catalyzes the stepwise 
addition of three acetyl groups to give a tetraketide which cyclizes 
into 2,3’,4,6-tetrahydroxybenzophenone. The T135L variant however 
is almost inactive with 3-hydroxy-benzoyl CoA as a starter substrate 
as the variant eliminates H-bonding between the enzyme and the 3-
hydroxyl group of the aryl moeity.  The 3-hydroxybenzoyl-primed 
triketide therefore becomes trapped in the new pocket of the T135L 
variant. Thus, the T135L substitution changes both the substrate and 
product specificity of BPS. 
 
Modifying enantiomeric selectivity 
 
One of the main advantages of using enzymes as catalysts for C-C 
bond formation is their stereoselectivity, which is important for 
synthesis of pharmaceutical drugs.  Examples of rational design of 
stereochemical control in C-C bond forming enzymes are discussed 
below.  
The class II pyruvate aldolase BphI exhibits strict stereochemical 
control as it can only utilize or produce the (4S) enantiomer of 4-
hydroxy-2-oxopentanoate [23]. Y290F and Y290S variants were 
found to lose stereochemical control and were able to catalyze aldol 
cleavage reactions of both (4S) and (4R) enantiomers of 4-hydroxy-
2-oxopentanoate with similar catalytic efficiencies [12]. This is 
consistent with the proposal that the p-hydroxyl of Tyr-290 in the 
wild-type enzyme sterically restricts the binding of the (4R)-
enantiomer and its removal in the Y290F or Y290S variants enables 
the enzyme to utilize this enantiomer. Modeling of the 4-hydroxy-2-
oxopentanoate in the active site of an orthologous enzyme placed the 
C4 chiral carbon between Leu-87 and Tyr-290 (Figure 3A) [12]. 
Replacement of Leu-87 with the polar asparagine (L87N) and the 
bulky tryptophan (L87W) residue were then attempted to create 
unfavorable polar-hydrophobic interactions or to introduce steric 
constraints to prevent binding of (4S) enantiomer.  The double 
mutants, L87N/Y290F and L87W/Y290F were observed to 
catalyze the cleavage of (4R)-hydroxyl-2-oxopentanoate and not the 
(4S) enantiomer [24] (Figure 3B). In these double variants, pyruvate 
binding was unaffected and the enzyme maintained stereospecificity 
for substrates of various lengths that is opposite to that of the wild-
type enzyme. 
Stereospecificity of a class I aldolase, 2-keto-3-deoxygluconate 
aldolase, has also been improved by rational design [25]. This enzyme 
exhibits broad specificity for the aldol addition reaction between 
pyruvate and non-phosphorylated aldehydes [26]. The wild-type 
enzyme exhibits poor diasterocontrol in many of its aldol reactions, 
including the reaction of its natural substrates, pyruvate and D-
glyeraldehyde producing a 55:45 racemate of D-2-keto-3-
deoxygluconate (D-KDGlu) and D-keto-3deoxy-galactonate (D-
KDGal) (Figure 4A). X-ray crystal structures of imine covalent 
complexes of this aldolase with pyruvate, D-KDGlu and D-KDGal 
have revealed that the carboxylate and C4-OH of D-KDGlu and D-
KDGal are stabilized by common interactions. However, the C5-OH 
of D-KDGlu makes water mediated H-bonding interactions with the 
enzyme  and  the  C6-OH  is  stabilized  by  direct  H-bonding  with  
Figure 3. Engineering stereospecificity in BphI. (A) Model of 4(S)-hydroxy-2-oxopentanoate in the active site of DmpG, an ortholog of BphI. The chiral C4 carbon 
is positioned between Leu-87 and the phenolic oxygen of Tyr-290. Carbon atoms of the substrate are colored cyan, and the carbon atoms of residues in the 
substrate binding sites are colored gray. Numbers correspond to residues in BphI. (B) To allow for binding of the 4-methyl in the 4(R)-enantiomer, the phenolic 
oxygen was removed with a Y290F variant.  At the same time, Leu87 was replaced with asparagine and tryptophan so that binding of the 4(S) enantiomer is 
disfavoured. 
 
Carbon-carbon bond forming enzymes 
4 
Volume No: 2, Issue: 3, September 2012, e201209003 Computational and Structural Biotechnology Journal | www.csbj.org 
 
 
 
 
 
 
 
 
 
Tyr-132 and water mediated hydrogen bonding with Thr-44, Ser-
241 and Asn-245 (Figure 4B). In comparison, the C5-OH of D-
KDGal H-bonds directly with Tyr-132 and the C6-OH interacts 
directly with Thr-44 (Figure 4C). This indicates that binding of D-
KDGlu is highly dependent on a conserved H-bond network 
composed of water molecules. Although Thr-157 plays a role in H-
bonding to the C4-OH of both diastereoisomers, it is more important 
for binding of D-KDGal (distance between C-hydroxyl of the 
threonine side chain and C4-OH of D-KDGal and D-KDGlu is 2.47 
Å and 3.07 Å, respectively). Thus, replacement of Thr-157 with 
residues of larger side chains, T157C and T157F, led to improved 
stereocontrol for D-KDGlu with 75% dr and 79% dr, respectively. 
To improve the stereochemical control for D-KDGlu, Tyr-132 that 
interacts directly with the C5-OH was replaced with valine. The 
Y132V variant catalyzed the selective formation of D-KDGlu in 
79% dr.  The Y132V/T157C and Y132V/T157F double variants 
were able to catalyze the formation of D-KDGlu with 91% dr and 
93%, respectively. A separate set of variants was created to increase 
the selectivity of the enzyme for KDGal by reducing the H-bonding 
network required for stabilization of KDGlu.  An A198L/T157G 
variant resulted in a small improvement in diastereocontrol, resulting 
in a preference for D-KDGal with a 72% dr.  Asp-181, which is 
oriented towards Leu-198 was subsequently substituted with Gln to 
lengthen this polar amino acid and further direct the hydrophobic 
side chain of Leu-198 towards C5-OH of D-KDGlu, thus 
destabilizing the interaction with this substrate.  In addition, the Leu-
198 side chain is thought to stabilize the C1-C3 hydrophobic face of 
the D-glyceraldehyde conformer of  D-KDGal. Indeed, the resulting 
triple variant A198L/T157G/D181Q was able to catalyze the 
diastereoselective formation of D-KDGal with 88 % dr.  However, 
improved stereoselectivity came with a >70-fold decrease in kcat. 
Carboxmethylproline synthases (CMPSs) belong to the crotonase 
superfamily of enzymes that catalyze an early step in carbapenem 
antibiotic  biosynthesis [27].   Under  standard  assay  conditions  the  
Figure 4. Engineering stereochemical control in 2-keto-3-deoxygluconate aldolase. (A) The wild-type aldolase catalyzes the nonstereoselective aldol addition 
reaction between pyruvate and D-glyceraldehyde. (B) X-ray structure of 2-keto-3-deoxygluconate aldolase from Sulfolobus sofataricus bound with D-KDGlu 
(PDB 1W3N).  D-KDGlu makes water mediated H-bonding interactions with the enzyme and the C6-OH is stabilized by direct H-bonding with Tyr-132 and water 
mediated hydrogen bonding with Thr-44, Ser-241 and Asn-245 (C) X-ray structure of 2-keto-3-deoxygluconate aldolase from Sulfolobus sofataricus bound with 
D-KDGal (PDB 1W3T). The C5-OH of bound D-KDGal hydrogen bonds directly with Tyr-132 and the C6-OH interacts directly with Thr-44. Structures are depicted 
in cartoon with active site residues shown as sticks. 
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CMPS from Pectobacterium carotovorum, known as CarB, catalyzes 
the reaction between L-GHP (an equilibrium mixture of L-glutamate 
semialdehyde, 5-hydroxyl-L-proline and L-pyrroline-5-carboxylate) 
with a C2 epimeric mixture of methylmalonyl-CoA to give a ~55:45 
mixture of (6R)- and (6S)-epimers of 6-methyl carboxymethylproline 
(6-methyl-t-CMP) [28]. While no crystal structure of CarB in 
complex with L-GHP is present, previous knowledge that the enolate 
anion formed during the reaction is likely bound in an oxyanion hole 
composed of the backbone amides of Met-108 and Gly-62 led to 
targeting of these residues for site-specific mutagenesis in an attempt 
to introduce stereochemical control (Figure 5). Residues, Gln-111 
and Trp-79 in CarB, thought to be involved in L-GHP binding, were 
also replaced by mutagenesis. Substitution of Met-108 in CarB with 
amino acid residues containing a -branch, such as valine or 
isoleucine, resulted in an enzyme that preferentially produced the 
(6R) products (≥95:5 for 6R:6S) possibly due to steric clash between 
the –methyl and reaction intermediates that result in the formation 
of the (6S) alkyl substituent product. Substitution of Trp-79 with 
alanine or phenylalanine on the other hand resulted in variants that 
preferentially produce the (6S) enantiomer product with ≥5:95 for 
6R:6S [29]. It was observed that W79F and W79A variants also have 
a ~10-fold increase in catalytic rate relative to the wild-type enzyme. 
While the chemical basis behind the diastereoselectivity exhibited in 
the variants mentioned is not clear, it is anticipated that these 
substitutions may influence the binding of alkylmalonyl-CoA and the 
catalytic rates of the two half reactions. 
 
Engineering novel functionalities 
 
Comparison of enzymes that share similarities in structure or 
reaction chemistry can be useful to engineer enzymes with novel 
functions.  
Alanine racemase and L-threonine aldolase are pyridoxal 5’-
phosphate (PLP)-dependent enzymes that are evolutionarily unrelated 
and have completely different tertiary and quaternary structures, 
substrate preferences and reaction specificities [30]. However both 
enzymes form aldimine intermediates between PLP and their 
respective substrates, alanine or β-hydroxy-α-amino acid. In threonine 
aldolase from Thermatoga maritima, His-83 is thought to be the 
catalytic base catalyzing the proton abstraction from the β-hydroxyl 
of the substrate. Alanine racemace of Geobacillus stearothermophilus 
also contains an active site histidine (His-166). This residue forms a 
hydrogen bond with Tyr-265 and functions to lower its pKa [31] and 
act as a base required to convert L- to D-alanine [32].  Removal of 
the hydrogen bond interaction between His-166 and Tyr-265 in the 
single Y265A variant of alanine racemase, resulted in an enzyme that 
exhibits aldolase activity with an apparent kcat/Km 2.3 × 105-fold 
higher than racemase activity in the wild-type enzyme [33]. Racemase 
activity in the Y265A variant was reduced 4 × 105-fold. The variant 
is also stereoselective, accepting only D-configured amino acids as 
substrates but displayed poor stereochemical control at the β carbon 
[34]. 
The enzyme 4-oxalocrontonate tautomerase (4-OT) catalyzes the 
conversion of 2-hydroxyhexa-2,4-dienedioate into 2-oxohex-3-
enedioate in the degradation of aromatic hydrocarbons [35]. The 
enzyme belongs to the tautomerase superfamily that contain a unique 
catalytic amino-terminal proline. Recently it was discovered that the 
enzyme has a secondary activity in its ability to catalyze the aldol 
condensation between acetaldehyde and benzaldehyde with a kcat/Km 
of 8.5 × 10-4 M-1 s-1 to yield cinnamaldehyde [36]. In the tautomerase 
reaction, Pro-1 of 4-OT acts as a nucleophile to form an enamine 
intermediate. In the presence of electrophiles, this nucleophilic 
intermediate can undergo carbon-carbon bond formation reactions. 
Therefore the promiscuous aldolase activity of OT is presumed to 
result from the cross-coupling of acetaldehyde and benzaldehyde to 
yield 3-hydroxy-3-phenylpropanal which subsequently undergoes 
dehydration to yield cinnamaldehyde. It has been proposed that the 
final hydrolysis step is rate limiting. In an attempt to increase this step 
in the reaction, Poelarends and co-workers used previous knowledge 
of a F50A variant that increased the accessibility of the active site to 
Figure 5. Proposed mechanism for the CMPS-catalyzed reaction. The decarboxylation of either alkylmalonyl-CoA enantiomer results in the formation of a either 
(E)- or  (Z)-enolate intermediate, which reacts with an imine to give a specific diastereomer of carboxymethyl-substituted N-heterocycles. 
Carbon-carbon bond forming enzymes 
6 
Volume No: 2, Issue: 3, September 2012, e201209003 Computational and Structural Biotechnology Journal | www.csbj.org 
the external aqueous environment without dramatic alterations to the 
pKa of Pro-1 [37]. The resulting F50A variant exhibited a 600-fold 
increase in kcat/Km in the aldol condensation reaction of acetaldehyde 
and benzaldehyde. 
Tyrosine phenol-lyase (TPL) is a PLP-dependent enzyme that is 
structurally similar to aspartate aminotransferase [38]. TPL catalyzes 
the β-elimination of L-tyrosine to produce phenol, pyruvate and 
ammonium. In an attempt to switch the substrate specificity of TPL 
from L-tyrosine to dicarboxylic amino acids, homology modeling 
indicated that Val-283 in TPL occupies the same position as Arg-
292 in aspartate aminotransferase, a residue that binds the carboxylate 
group in the aspartate side chain. Arg-100 in TPL on the other hand 
corresponds to Thr-109 in aspartate aminotransferase, which interacts 
with the phosphate group of PLP. In the R100T/V283R double 
variant of TPL the β-elimination reaction towards dicarboxylic acids 
increase by at least 104-fold compared to the wild-type enzyme and 
the rate of β-elimination using L-aspartate as substrate was 2-fold 
higher rate than that of L-tyrosine [39]. The rate of β-elimination 
was only one order of magnitude slower than that of L-tyrosine in the 
wild-type enzyme. Thus, the R100T/V283R variant was converted 
to a dicarboxylic amino acid β-lyase, an enzyme not found in nature 
without significant change to its reaction specificity. 
The elimination of one catalytic function can also lead to the 
improvement of another secondary catalytic function. Pyruvate 
decarboxylase (PDC) is a thiamin diphosphate dependent enzyme 
that catalyzes the decarboxylation of pyruvate to form acetaldehyde 
and carbon dioxide in the presence of Mg2+ (Figure 6) [40].  The 
enzyme is also able to catalyze a carboligation side reaction, whereby 
the carbanion/enamine intermediate, following decarboxylation of 
pyruvate, reacts with excess or exogenous aldehydes, to form 2-
hydroxy ketones such as (R)-phenylacetyl carbinol, the precursor of 
several antiasthmatics such as ephedrine, pseudoephedrine, and 
norephedrine [41]. Kinetic and thermodynamic single-step analysis in 
conjunction with the X-ray crystal structure of PDC from 
Zymomonas mobilis implicated an active site residue Glu-473 in 
donating a proton to the 2-hydroxyethyl-ThDP carbanion/enamine 
intermediate to form acetaldehyde [42]. Consequently, in the E473Q 
variant, the protonation step occurs 2000-fold slower than the wild-
type enzyme, and the catalytic cycle stalls at the carbanion/enamine 
intermediate state following pyruvate decarboxylation.  Therefore this 
variant is more efficient at catalyzing formation of (R)-PAC in the 
presence of benzaldehyde [43]. The high enantioselectivity of the 
wild-type enzyme is retained in the variant. 
 
 
 
 
 
  
 
 
 
De novo rational computation design 
 
The ultimate goal in rational protein design is the creation 
enzymes de novo i.e. creating synthetic protein catalysts.  De novo 
design involves the selection of a catalytic mechanism for the desired 
reaction and modeling the reaction transition state(s). A protein 
scaffold is then designed to accommodate and stabilize the transition 
state. Usually several enzymes are produced, ranked and 
experimentally evaluated.  C-C bond forming reactions are one of the 
best understood chemical reactions and not surprisingly some of the 
most successful examples of de novo designed enzymes are those that 
catalyze this reaction.  
Aldolases of the Class I type that form a Schiff base intermediate 
with a catalytic lysine [9, 44] were designed to catalyze the carbon-
carbon bond cleavage of 4-hydroxy-4-(6-methoxy-2-naphthyl)-2-
butanone, a compound not found in biological systems (Figure 7A) 
[45]. Four active site motifs with differing catalytic lysine 
environments, carbinolamine stabilization and proton abstraction 
were generated on five different protein scaffolds belonging to the 
triose phosphate-isomerase (TIM)-barrel and jelly-roll folds [46]. Of 
the 72 designs that were selected and experimentally characterized, 32 
exhibited detectable aldolase activity. The most significant rate 
enhancement (kcat/kuncat of 2 × 104) was accomplished through a 
catalytic lysine in a hydrophobic environment with a water molecule 
stabilizing the carbinolamine intermediate and catalyzing the proton 
abstraction of the C4-OH group of the substrate. Replacement of the 
putative catalytic lysine in all models dramatically decreased or 
abolished catalysis completely, suggesting that the observed activity 
was due to the formation of a schiff base intermediate with the 
substrate. Structures of two of the designed enzymes were solved, 
which showed that the active site residues superimpose well on the 
original design. 
To date, no natural enzyme has been demonstrated to catalyze an 
intermolecular Diels-Alder reaction.  Therefore de-novo rational 
design of an enzyme that catalyze a pericyclic [4 + 2] cycloaddition 
between a conjugated diene and a dienophile to form a substituted 
chiral cyclohexene compound, forming two carbon-carbon bonds and 
up to four new stereogenic centers in one step, was attempted. In the 
well-studied Diels-Alder reaction between 4-carboxybenzyl trans-1,3-
butadiene-1 carbamate and N,N-dimethylacrylamide, the dominant 
interaction in the transition state is the highest occupied molecular 
orbital (HOMO) of the diene, 4-carboxybenzyl trans-1,3-butadiene-
1 carbamate with the lowest unoccupied molecular orbital (LUMO) 
of the dienophile, N,N-dimethylacrylamide (Figure 7B). Thus, 
narrowing the energy gap between HOMO and LUMO is predicted 
to increase the rate of the reaction. An enzyme was devised whereby a 
hydrogen bond acceptor was positioned to interact with the carbamate 
NH of the diene, raising the energy of the HOMO energy while a 
hydrogen bond donor interacts with the carbonyl of the dienophile, 
lowering the LUMO energy. A binding pocket was also designed to 
position the substrates in the proper relative orientation by 
incorporating functional groups that can form hydrogen bonds with 
the substrates. Out of 207 stable protein scaffolds with backbone 
geometries that allow for orientation of the catalytic residues relative 
to the substrates, 84 designs were selected, 50 of which were soluble 
and can be purified [47]. Two enzymes with different scaffolds 
exhibited Diels-Alderase activity. The structure of one of these 
designs was solved using X-ray crystallography and showed agreement 
with the design model with a RMSD of 0.5 Å. 
A challenge in de novo designed enzymes is that the protein backbone 
structure is not optimized for substrate binding or catalysis, resulting 
in low catalytic efficiencies. Directed evolution approaches are one 
way to circumvent the need for precise backbone modeling to enhance  
Figure 6. Half reaction of pyruvate decarboxylase. In the wild-type 
enzyme, protonation of the 2-hydroxyethyl-thiamin diphosphate 
intermediate leads to the release of acetaldehyde. In the E473Q variant, 
protonation occurs more slowly thus allowing for carboligation of 
benzaldehyde with the intermediate leading to the formation of (R)-
phenylacetyl carbinol, a precursor of (-)-ephedrine.  
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the catalytic efficiency of designed enzymes.  An alternative approach 
is to enlist the aid of the internet community to perform time 
consuming human interpretation and judgment required for modeling 
of protein backbone structure.  This has been successfully 
implemented in the crowdsourcing program foldit. Users (players) 
designed enzyme was found to improve the catalytic efficiency of the 
diels alderase mentioned above by up to 19-fold [48]. 
 
Summary 
 
The examples discussed above demonstrate that it is possible to 
alter the function carbon-carbon bond forming enzymes using 
knowledge based, rational approaches. Ultimately, such studies also 
strengthen our understanding of protein structure-function 
relationships that will in turn advance our ability to engineer proteins 
with desired functions with greater precision.    
 
 
 
 
 
 
 
 
Figure 7. Chemical reactions catalyzed by de novo designed enzymes. (A) The retro-aldol reaction involves the formation of a Schiff base intermediate 
between a catalytic lysine and the substrate 4-hdyroxy-4-(6-methyoxy-2naphthyl)-2-butanone. C-C bond cleavage occurs following proton abstraction at the 
C4-OH of the substrate forming 2-propanone and 6-methoxynaphthalene-2-carbaldehyde. (B) The Diels-Alder reaction occurs between a dienophile I (4-
carboxy trans 1,3-butadiene-1-carbamate) and diene II (N,N-dimethylacrylamide) which undergoes a pericyclic [4+2] cycloaddition to form a chiral cyclohexene 
ring. 
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